Traditional and emerging risk factors for cardiovascular disease

被引：22

作者：

Eaton, CB

机构：

[1] Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA

[2] Brown Med Sch, Providence, RI 02912 USA

来源：

PRIMARY CARE | 2005年 / 32卷 / 04期

关键词：

D O I：

10.1016/j.pop.2005.09.009

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Cardiovascular disease (CVD) is the leading cause of death in the United States and most western societies, further, approximately 50% of CVD is related to coronary heart disease (CHD). Most CVD results from an athero-thrombotic pathologic process in the body's arterial beds, and is largely preventable through risk factor reduction. Risk factors are diseases, physiologic states, biologic markers, or other identifiable factors associated with increased incidence of CVD. This article breaks down traditional, emerging, and possible risk factors for discussion.

引用

收藏

页码：963 / +

页数：15

相关论文

共 42 条

[31] C-reactive protein levels and outcomes after statin therapy [J].

Ridker, PM ;

Cannon, CP ;

Morrow, D ;

Rifai, N ;

Rose, LM ;

McCabe, CH ;

Pfeffer, MA ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01) :20-28

[32] C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women [J].

Ridker, PM ;

Hennekens, CH ;

Buring, JE ;

Rifai, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (12) :836-843

[33] PROSPECTIVE-STUDY OF ALCOHOL-CONSUMPTION AND RISK OF CORONARY-DISEASE IN MEN [J].

RIMM, EB ;

GIOVANNUCCI, EL ;

WILLETT, WC ;

COLDITZ, GA ;

ASCHERIO, A ;

ROSNER, B ;

STAMPFER, MJ .

LANCET, 1991, 338 (8765) :464-468

[34] INTRAINDIVIDUAL VARIABILITY OF FIBRINOGEN LEVELS AND CARDIOVASCULAR RISK PROFILE [J].

ROSENSON, RS ;

TANGNEY, CC ;

HAFNER, JM .

ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (12) :1928-1932

[35] Kidney disease as a risk factor for development of cardiovascular disease - A statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention [J].

Sarnak, MJ ;

Levey, AS ;

Schoolwerth, AC ;

Coresh, J ;

Culleton, B ;

Hamm, LL ;

McCullough, PA ;

Kasiske, BL ;

Kelepouris, E ;

Klag, MJ ;

Parfrey, P ;

Pfeffer, M ;

Raij, L ;

Spinosa, DJ ;

Wilson, PW .

CIRCULATION, 2003, 108 (17) :2154-2169

[36] Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis [J].

Solomon, DH ;

Karlson, EW ;

Rimm, EB ;

Cannuscio, CC ;

Mandl, LA ;

Manson, JE ;

Stampfer, MJ ;

Curhan, GC .

CIRCULATION, 2003, 107 (09) :1303-1307

[37] FAMILIAL HYPERCHOLESTEROLEMIA REGRESSION STUDY - A RANDOMIZED TRIAL OF LOW-DENSITY-LIPOPROTEIN APHERESIS [J].

THOMPSON, GR ;

MAHER, VMG ;

MATTHEWS, S ;

KITANO, Y ;

NEUWIRTH, C ;

SHORTT, MB ;

DAVIES, G ;

REES, A ;

MIR, A ;

PRESCOTT, RJ ;

DEFEYTER, P ;

HENDERSON, A .

LANCET, 1995, 345 (8953) :811-816

[38] Plasma natriuretic peptide levels and the risk of cardiovascular events and death [J].

Wang, TJ ;

Larson, MG ;

Levy, D ;

Benjamin, EJ ;

Leip, EP ;

Omland, T ;

Wolf, PA ;

Vasan, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) :655-663

[39]

WILHELMSSON C, 1975, LANCET, V1, P416

[40] Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (The Health Family Tree Study and the NHLBI Family Heart Study) [J].

Williams, RR ;

Hunt, SC ;

Heiss, G ;

Province, MA ;

Bensen, JT ;

Higgins, M ;

Chamberlain, RM ;

Ware, J ;

Hopkins, PN .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (02) :129-135

← 1 2 3 4 5 →